19-10489360-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_203500.2(KEAP1):c.1540G>A(p.Val514Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,612,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_203500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KEAP1 | NM_203500.2 | c.1540G>A | p.Val514Ile | missense_variant | 5/6 | ENST00000171111.10 | NP_987096.1 | |
KEAP1 | NM_012289.4 | c.1540G>A | p.Val514Ile | missense_variant | 5/6 | NP_036421.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KEAP1 | ENST00000171111.10 | c.1540G>A | p.Val514Ile | missense_variant | 5/6 | 1 | NM_203500.2 | ENSP00000171111.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000120 AC: 30AN: 250204Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135196
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1460632Hom.: 0 Cov.: 33 AF XY: 0.0000454 AC XY: 33AN XY: 726454
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2024 | The c.1540G>A (p.V514I) alteration is located in exon 5 (coding exon 4) of the KEAP1 gene. This alteration results from a G to A substitution at nucleotide position 1540, causing the valine (V) at amino acid position 514 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at